Simulations Plus, Inc.(SLP)Earnings, Financials & Key Ratios

SLP•NASDAQ

$15.88

$320M mkt cap·Price updated May 6, 2026

SectorHealthcare IndustryHealthcare IT Sub-IndustryLife Sciences and Precision Medicine Software

AboutSimulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. It also provides products based on mechanistic and mathematical models, such as DILIsym, a quantitative systems pharmacology software; NAFLDsym; IPFsym; RENAsym; and MITOsym. In addition, the company provides Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as modeling and simulation products comprising MonolixSuite and PKPlus. Further, it provides population modeling and simulation contract research services; training and consulting services designed to accelerate pharmacometrics studies; and clinical-pharmacology-based consulting services in support of regulatory submissions. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.Show more

Revenue$79M+13.1%
EBITDA-$63M-630.0%
Net Income-$65M-750.2%
EPS (Diluted)-3.22-757.1%
Gross Margin58.38%-5.3%
EBITDA Margin-78.96%-568.6%
Operating Margin-89.33%-1120.1%
Net Margin-81.74%-674.9%
ROE-42.13%-845.9%
ROIC-39.63%-1336.1%
Debt/Equity0.00-10.5%

Technical→

SLP Key Insights

Simulations Plus, Inc. (SLP) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

✓Company is almost debt free
✓FCF machine: 22.0% free cash flow margin
✓Strong 5Y sales CAGR of 13.7%

✗Weaknesses

✗Trading more than 30% below 52-week high

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

SLP Price & Volume

Simulations Plus, Inc. (SLP) stock price & volume — 10-year historical chart

Loading chart...

SLP Growth Metrics

Simulations Plus, Inc. (SLP) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years15.77%

5 Years13.74%

3 Years13.67%

TTM5.69%

Profit CAGR

10 Years-

5 Years-

3 Years-

TTM-882.08%

EPS CAGR

10 Years-

5 Years-

3 Years-

TTM-895.72%

Return on Capital

10 Years9.99%

5 Years-4.17%

3 Years-12.01%

Last Year-44.1%

SLP Recent Earnings

Simulations Plus, Inc. (SLP) EPS & revenue vs analyst estimates — last 4 quarters

Full history →

●Beat EPS 4/12 qtrs (33%)●Beat Revenue 7/12 qtrs (58%)

Q2 2026Latest

Apr 9, 2026

EPS

$0.35

Est $0.27

+29.6%

Revenue

$24M

Est $22M

+12.2%

Q1 2026

Jan 8, 2026

EPS

$0.13

Est $0.18

-27.8%

Revenue

$18M

Est $18M

+2.0%

Q4 2025

Dec 1, 2025

EPS

$0.10

Est $0.10

+0.0%

Revenue

$17M

Est $17M

+0.4%

Q3 2025

Jul 14, 2025

EPS

$0.45

Est $0.26

+73.1%

Revenue

$20M

Est $21M

-2.7%

Quarter	Date	EPS (Act vs Est)	Revenue (Act vs Est)
Q2 2026Latest	Apr 9, 2026	$0.35vs $0.27+29.6%	$24Mvs $22M+12.2%
Q1 2026	Jan 8, 2026	$0.13vs $0.18-27.8%	$18Mvs $18M+2.0%
Q4 2025	Dec 1, 2025	$0.10vs $0.10+0.0%	$17Mvs $17M+0.4%
Q3 2025	Jul 14, 2025	$0.45vs $0.26+73.1%	$20Mvs $21M-2.7%

Based on last 12 quarters of dataView full earnings history →

Company	Market Cap	Stock Price	P/E Ratio (TTM)	Revenue Growth 1Y	Net Margin	Return on Equity (ROE)	Debt / Equity
VEEVVeeva Systems Inc.Direct Competitor	27.2B	167.29	30.75	16.34%	28.44%	13.41%	0.01
CERTCertara, Inc.Direct Competitor	1.03B	6.26	-626	8.75%	-0.38%	-0.15%	0.01
SCYXSCYNEXIS, Inc.Direct Competitor	42.75M	0.98	-5.78	449.95%	-41.79%	-19.05%	0.04
DSGNDesign Therapeutics, Inc.Product Competitor	908.75M	14.55	-11.93			-33.07%	0.00
SDGRSchrödinger, Inc.Product Competitor	969.87M	12.98	-9.21	23.29%	-40.6%	-30.85%	0.30
RXRXRecursion Pharmaceuticals, Inc.Product Competitor	1.53B	3.43	-2.38	26.92%	-8.44%	-54.32%	0.07
ABSIAbsci CorporationProduct Competitor	924.91M	5.95	-7.08	-38.24%	-41.14%	-59.68%	0.03
TMOThermo Fisher Scientific Inc.Supply Chain	175.76B	472.95	26.66	3.91%	15.18%	13.23%	0.76

Compare SLP vs Peers

Simulations Plus, Inc. (SLP) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs VEEV

Most directly comparable listed peer for SLP.

Scale Benchmark

vs TMO

Larger-name benchmark to compare SLP against a more recognizable public peer.

Peer Set

Compare Top 5

vs VEEV, CERT, SCYX, DSGN

SLP Income Statement

Simulations Plus, Inc. (SLP) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily

Line item	Aug'17	Aug'18	Aug'19	Aug'20	Aug'21	Aug'22	Aug'23	Aug'24	Aug'25	TTM
Sales/Revenue	24.14M	29.67M	33.97M	41.59M	46.47M	53.91M	59.58M	70.01M	79.18M	78.68M
Revenue Growth %	20.86%	22.9%	14.51%	22.43%	11.73%	16.01%	10.52%	17.52%	13.09%	5.69%
Cost of Goods Sold	6.31M	7.99M	9.03M	10.65M	10.6M	10.82M	11.63M	26.86M	32.96M	31.78M
COGS % of Revenue	26.13%	26.95%	26.57%	25.61%	22.81%	20.08%	19.52%	38.37%	41.62%	-
Gross Profit	17.83M▲ 0%	21.67M▲ 21.5%	24.94M▲ 15.1%	30.94M▲ 24.0%	35.87M▲ 15.9%	43.08M▲ 20.1%	47.95M▲ 11.3%	43.15M▼ 10.0%	46.22M▲ 7.1%	46.89M▲ 0%
Gross Margin %	73.87%	73.05%	73.43%	74.39%	77.19%	79.92%	80.48%	61.63%	58.38%	59.6%
Gross Profit Growth %	16%	21.55%	15.1%	24.04%	15.92%	20.12%	11.29%	-10%	7.11%	-
Operating Expenses	9.57M	11.37M	14.3M	19.34M	24.61M	28.17M	39.22M	37.02M	116.95M	117.04M
OpEx % of Revenue	39.63%	38.34%	42.08%	46.49%	52.97%	52.26%	65.83%	52.88%	147.7%	-
Selling, General & Admin	8.2M	9.58M	11.8M	16.36M	20.57M	24.96M	34.72M	31.27M	32.84M	31.8M
SG&A % of Revenue	33.96%	32.31%	34.72%	39.34%	44.26%	46.31%	58.27%	44.66%	41.48%	-
Research & Development	1.37M	1.79M	2.5M	2.98M	4.05M	3.21M	4.5M	5.75M	6.88M	8.02M
R&D % of Revenue	5.67%	6.04%	7.36%	7.15%	8.71%	5.95%	7.56%	8.22%	8.69%	-
Other Operating Expenses	0	0	0	0	0	0	0	0	77.22M	1000K
Operating Income	8.26M▲ 0%	10.3M▲ 24.6%	10.65M▲ 3.4%	11.61M▲ 9.0%	11.25M▼ 3.0%	14.91M▲ 32.5%	8.72M▼ 41.5%	6.13M▼ 29.7%	-70.73M▼ 1253.6%	-70.14M▲ 0%
Operating Margin %	34.24%	34.71%	31.35%	27.9%	24.22%	27.66%	14.64%	8.76%	-89.33%	-89.15%
Operating Income Growth %	14.28%	24.61%	3.4%	8.99%	-3.03%	32.51%	-41.49%	-29.73%	-1253.63%	-
EBITDA	10.4M	13.02M	13.4M	14.57M	14.84M	18.48M	12.56M	11.8M	-62.52M	-62.85M
EBITDA Margin %	43.08%	43.88%	39.44%	35.03%	31.94%	34.29%	21.09%	16.85%	-78.96%	-79.88%
EBITDA Growth %	13.48%	25.19%	2.91%	8.73%	1.89%	24.54%	-32.03%	-6.12%	-629.99%	-617.88%
D&A (Non-Cash Add-back)	2.14M	2.72M	2.75M	2.96M	3.59M	3.57M	3.84M	5.67M	8.21M	7.29M
EBIT	8.28M	10.3M	10.56M	11.39M	11.11M	15.12M	9.22M	6.13M	6.49M	7.34M
Net Interest Income	-22.33K	27.12K	34K	30K	179K	717K	4.13M	4.38M	722K	830K
Interest Income	15.86K	27.12K	34K	30K	201K	717K	4.13M	4.38M	722K	830K
Interest Expense	38.19K	0	0	0	22K	0	0	0	0	0
Other Income/Expense	-24.02K	-158.85K	-92K	-218K	-168K	204K	2.97M	6.28M	1.35M	1.47M
Pretax Income	8.24M▲ 0%	10.14M▲ 23.0%	10.56M▲ 4.1%	11.39M▲ 7.9%	11.09M▼ 2.7%	15.12M▲ 36.4%	11.7M▼ 22.6%	12.41M▲ 6.1%	-69.38M▼ 659.0%	-68.68M▲ 0%
Pretax Margin %	34.14%	34.18%	31.07%	27.38%	23.86%	28.04%	19.63%	17.73%	-87.62%	-87.29%
Income Tax	2.45M	1.2M	1.97M	2.06M	1.3M	2.63M	1.73M	2.46M	-4.66M	-4.43M
Effective Tax Rate %	29.76%	11.88%	18.69%	18.05%	11.75%	17.41%	14.83%	19.8%	6.72%	6.45%
Net Income	5.79M▲ 0%	8.93M▲ 54.4%	8.58M▼ 3.9%	9.33M▲ 8.7%	9.78M▲ 4.8%	12.48M▲ 27.6%	9.96M▼ 20.2%	9.95M▼ 0.1%	-64.72M▼ 750.2%	-64.25M▲ 0%
Net Margin %	23.98%	30.12%	25.27%	22.44%	21.05%	23.16%	16.72%	14.22%	-81.74%	-81.66%
Net Income Growth %	16.92%	54.38%	-3.94%	8.73%	4.82%	27.61%	-20.2%	-0.07%	-750.17%	-882.08%
Net Income (Continuing)	5.79M	8.93M	8.58M	9.33M	9.78M	12.48M	9.96M	9.95M	-64.72M	-64.25M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	0.33▲ 0%	0.50▲ 51.5%	0.48▼ 4.0%	0.50▲ 4.2%	0.47▼ 6.0%	0.60▲ 27.7%	0.49▼ 18.3%	0.49▲ 0.0%	-3.22▼ 757.1%	-3.18▲ 0%
EPS Growth %	13.79%	51.52%	-4%	4.17%	-6%	27.66%	-18.33%	0%	-757.14%	-895.72%
EPS (Basic)	0.34	0.52	0.49	0.52	0.49	0.62	0.50	0.50	-3.22	-
Diluted Shares Outstanding	17.52M	17.86M	18.06M	18.54M	20.74M	20.75M	20.46M	20.3M	20.1M	20.22M
Basic Shares Outstanding	17.24M	17.33M	17.49M	17.82M	20.05M	20.2M	20.07M	19.99M	20.1M	20.14M
Dividend Payout Ratio	59.58%	46.58%	48.9%	45.55%	49.18%	38.82%	48.28%	48.18%	-	-

SLP Balance Sheet

Simulations Plus, Inc. (SLP) balance sheet — assets, liabilities & shareholders' equity

Line item	Aug'17	Aug'18	Aug'19	Aug'20	Aug'21	Aug'22	Aug'23	Aug'24	Aug'25	TTM
Total Current Assets	12.67M	17.82M	21.17M	129.09M	139.31M	146.79M	130.37M	39.34M	51.55M	58.14M
Cash & Short-Term Investments	6.22M	9.4M	11.44M	116.01M	123.6M	128.24M	115.46M	20.25M	32.35M	35.69M
Cash Only	6.22M	9.4M	11.44M	49.21M	36.98M	51.57M	57.52M	10.31M	30.85M	30.19M
Short-Term Investments	0	0	0	66.8M	86.62M	76.67M	57.94M	9.94M	1.5M	5.5M
Accounts Receivable	5.53M	7.5M	8.26M	10.52M	13.05M	13.79M	10.2M	9.14M	14.62M	12.15M
Days Sales Outstanding	83.62	92.28	88.75	92.28	102.52	93.35	62.5	47.63	67.38	67.32
Inventory	462.44K	312.59K	765.11K	969.69K	1.01M	1.39M	804K	0	0	0
Days Inventory Outstanding	26.76	14.27	30.94	33.24	34.85	46.92	25.23	-	-	-
Other Current Assets	459.9K	610.44K	704.32K	1.6M	1.65M	3.38M	3.9M	7.75M	2.8M	10.3M
Total Non-Current Assets	25.84M	26.33M	24.93M	40.73M	42.3M	43.71M	62.27M	168.3M	80.39M	79.69M
Property, Plant & Equipment	291.13K	335.22K	341.14K	1.36M	3.11M	2.05M	1.92M	1.84M	1.29M	1.18M
Fixed Asset Turnover	82.91x	88.50x	99.58x	30.48x	14.92x	26.27x	31.06x	38.07x	61.52x	60.49x
Goodwill	10.39M	10.39M	10.39M	12.92M	12.92M	12.92M	19.1M	96.08M	43.72M	43.72M
Intangible Assets	15.13M	14.7M	13.27M	24.99M	24.58M	26.18M	32.85M	58.84M	29.21M	28.8M
Long-Term Investments	0	0	0	0	0	0	0	0	0	0
Other Non-Current Assets	34.08K	37.23K	37.23K	50.97K	51K	439K	425K	542K	1.4M	3.67M
Total Assets	38.51M▲ 0%	44.15M▲ 14.6%	46.09M▲ 4.4%	169.82M▲ 268.4%	181.61M▲ 6.9%	190.5M▲ 4.9%	192.64M▲ 1.1%	207.64M▲ 7.8%	131.94M▼ 36.5%	137.83M▲ 0%
Asset Turnover	0.63x	0.67x	0.74x	0.24x	0.26x	0.28x	0.31x	0.34x	0.60x	0.52x
Asset Growth %	38.46%	14.64%	4.41%	268.41%	6.95%	4.89%	1.12%	7.78%	-36.46%	-92.89%
Total Current Liabilities	2.04M	4.83M	4.78M	5.5M	11.57M	7.74M	11.99M	12.07M	6.72M	10.34M
Accounts Payable	240.89K	351.61K	204.07K	351K	387K	225K	144K	602K	470K	863K
Days Payables Outstanding	13.94	16.05	8.25	12.03	13.33	7.59	4.52	8.18	5.21	12.06
Short-Term Debt	0	0	0	463.46K	382K	461K	442K	475K	206K	179K
Deferred Revenue (Current)	570.92K	766.53K	1.18M	440.47K	651K	2.86M	3.1M	2M	2.7M	16.11M
Other Current Liabilities	1.23M	3.71M	3.4M	4.25M	10.15M	931K	3.91M	4.48M	1.34M	922K
Current Ratio	6.20x	3.69x	4.42x	23.45x	12.04x	18.98x	10.88x	3.26x	7.67x	7.67x
Quick Ratio	5.98x	3.63x	4.26x	23.28x	11.95x	18.80x	10.81x	3.26x	7.67x	7.67x
Cash Conversion Cycle	96.44	90.5	111.44	113.49	124.04	132.68	83.21	-	-	55.26
Total Non-Current Liabilities	10.67M	7.4M	3.63M	8.28M	4.26M	4.52M	10.62M	13.14M	410K	378K
Long-Term Debt	0	0	0	0	0	0	0	0	0	0
Capital Lease Obligations	0	0	0	463.31K	896K	943K	755K	531K	410K	1.72M
Deferred Tax Liabilities	4.93M	4.07M	3.63M	3.75M	3.36M	3.58M	6.54M	12.61M	0	701K
Other Non-Current Liabilities	5.74M	3.33M	0	4.06M	0	0	3.33M	0	0	0
Total Liabilities	12.71M	12.23M	8.41M	13.78M	15.83M	12.26M	22.61M	25.21M	7.13M	10.72M
Total Debt	0	0	0	926.78K	1.28M	1.4M	1.2M	1.01M	616K	557K
Net Debt	-6.22M	-9.4M	-11.44M	-48.28M	-35.71M	-50.16M	-56.33M	-9.3M	-30.24M	-29.63M
Debt / Equity	-	-	-	0.01x	0.01x	0.01x	0.01x	0.01x	0.00x	0.00x
Debt / EBITDA	-	-	-	0.06x	0.09x	0.08x	0.10x	0.09x	-	-0.01x
Net Debt / EBITDA	-0.60x	-0.72x	-0.85x	-3.31x	-2.41x	-2.71x	-4.48x	-0.79x	-	0.47x
Interest Coverage	216.41x	-	-	-	511.50x	-	-	-	-	-
Total Equity	25.8M▲ 0%	31.92M▲ 23.7%	37.68M▲ 18.0%	156.04M▲ 314.1%	165.78M▲ 6.2%	178.25M▲ 7.5%	170.03M▼ 4.6%	182.43M▲ 7.3%	124.8M▼ 31.6%	127.11M▲ 0%
Equity Growth %	13.51%	23.71%	18.04%	314.09%	6.25%	7.52%	-4.61%	7.29%	-31.59%	-87.26%
Book Value per Share	1.47	1.79	2.09	8.42	7.99	8.59	8.31	8.99	6.21	6.29
Total Shareholders' Equity	25.8M	31.92M	37.68M	156.04M	165.78M	178.25M	170.03M	182.43M	124.8M	127.11M
Common Stock	7.28K	7.42K	7.59K	9.93K	133.42M	138.51M	144.97M	20K	20K	20K
Retained Earnings	13.69M	18.46M	22.35M	27.44M	32.41M	40.04M	25.2M	30.35M	-34.36M	-33.69M
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	0	0	0	58.47K	-43K	-308K	-141K	-251K	-271K	-277K
Minority Interest	0	0	0	0	0	0	0	0	0	0

SLP Cash Flow Statement

Simulations Plus, Inc. (SLP) cash flow — operating, investing & free cash flow history

Line item	Aug'17	Aug'18	Aug'19	Aug'20	Aug'21	Aug'22	Aug'23	Aug'24	Aug'25	TTM
Cash from Operations	6.88M	9.29M	11.64M	10.91M	19.2M	17.9M	21.86M	13.32M	18.13M	18.13M
Operating CF Margin %	28.49%	31.31%	34.26%	26.24%	41.33%	33.21%	36.69%	19.02%	22.89%	-
Operating CF Growth %	27.01%	35.03%	25.32%	-6.24%	75.98%	-6.79%	22.1%	-39.06%	36.08%	708.95%
Net Income	5.79M	8.93M	8.58M	9.33M	9.78M	12.48M	9.96M	9.95M	-64.72M	-64.25M
Depreciation & Amortization	2.14M	2.72M	2.75M	2.96M	3.59M	3.57M	3.84M	5.67M	8.21M	7.29M
Stock-Based Compensation	585.02K	709.08K	1.08M	1.58M	2.75M	3.04M	4.83M	6.54M	6.35M	6.25M
Deferred Taxes	-178.37K	-1.73M	-299.1K	-377.76K	-628K	-270K	-2.1M	-1.76M	-5.43M	-5.3M
Other Non-Cash Items	74.95K	152.75K	109.06K	202.03K	2.73M	1.7M	219K	-2.86M	76.29M	76.44M
Working Capital Changes	-1.53M	-1.5M	-582.96K	-2.78M	974K	-2.62M	5.1M	-4.21M	-2.59M	3.21M
Change in Receivables	-876.23K	-1.47M	487.97K	-2.02M	-2.43M	-3.94M	4.1M	3.13M	-581K	650K
Change in Inventory	-378.99K	-339.46K	-1.31M	-247.25K	3.15M	0	0	0	0	0
Change in Payables	99.34K	110.71K	-147.53K	220.58K	39K	-162K	-81K	-477K	-132K	-257K
Cash from Investing	-4.36M	-2.33M	-1.96M	-75.51M	-26.74M	4.3M	7.37M	-53.97M	3.56M	1.8M
Capital Expenditures	-1.56M	-2.33M	-1.96M	-2.58M	-4.58M	-3.97M	-4.27M	-566K	-713K	-1.53M
CapEx % of Revenue	6.46%	7.85%	5.76%	6.21%	9.85%	7.36%	7.17%	0.81%	0.9%	-
Acquisitions	-2.8M	0	0	-5.67M	2.95M	3.15M	-8.22M	-98.77M	0	0
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	-1.38M	-2.15M	0	-2.35M	-2.95M	-3.15M	0	-3.73M	-4.24M	-3.19M
Cash from Financing	-4.34M	-3.77M	-7.65M	102.37M	-4.68M	-7.62M	-23.27M	-6.57M	-1.15M	-1.43M
Debt Issued (Net)	0	0	0	0	0	0	0	0	0	0
Equity Issued (Net)	0	0	0	1000K	1000K	891K	-1000K	731K	430K	144K
Dividends Paid	-3.45M	-4.16M	-4.2M	-4.25M	-4.81M	-4.85M	-4.81M	-4.8M	0	0
Share Repurchases	0	0	0	0	0	0	-20M	0	0	0
Other Financing	-888.6K	388.25K	-3.45M	-1.13M	-1.33M	-3.67M	1.54M	-2.5M	-1.58M	-1.58M
Net Change in Cash	-1.81M▲ 0%	3.18M▲ 275.5%	2.03M▼ 36.1%	37.77M▲ 1756.3%	-12.22M▼ 132.4%	14.58M▲ 219.3%	5.96M▼ 59.2%	-47.21M▼ 892.7%	20.54M▲ 143.5%	24M▲ 0%
Free Cash Flow	5.32M▲ 0%	6.96M▲ 30.8%	9.68M▲ 39.1%	8.33M▼ 14.0%	14.63M▲ 75.6%	13.93M▼ 4.8%	17.58M▲ 26.2%	12.75M▼ 27.5%	17.41M▲ 36.5%	23.01M▲ 0%
FCF Margin %	22.03%	23.46%	28.5%	20.02%	31.48%	25.84%	29.51%	18.22%	21.99%	29.24%
FCF Growth %	27.22%	30.85%	39.15%	-14%	75.65%	-4.77%	26.22%	-27.46%	36.53%	167.68%
FCF per Share	0.30	0.39	0.54	0.45	0.71	0.67	0.86	0.63	0.87	0.87
FCF Conversion (FCF/Net Income)	1.19x	1.04x	1.36x	1.17x	1.96x	1.43x	2.19x	1.34x	-0.28x	-0.36x
Interest Paid	0	0	0	0	0	0	0	0	0	0
Taxes Paid	2.69M	2.71M	2.67M	2.35M	1.86M	3.23M	3.2M	5.69M	1.16M	-112K

SLP Key Ratios

Simulations Plus, Inc. (SLP) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric	2017	2018	2019	2020	2021	2022	2023	2024	2025	TTM
Return on Equity (ROE)	23.85%	30.96%	24.66%	9.63%	6.08%	7.26%	5.72%	5.65%	-42.13%	-50.54%
Return on Invested Capital (ROIC)	36.15%	36.68%	32.75%	12.99%	7.1%	8.66%	5.41%	3.21%	-39.63%	-39.63%
Gross Margin	73.87%	73.05%	73.43%	74.39%	77.19%	79.92%	80.48%	61.63%	58.38%	59.6%
Net Margin	23.98%	30.12%	25.27%	22.44%	21.05%	23.16%	16.72%	14.22%	-81.74%	-81.66%
Debt / Equity	-	-	-	0.01x	0.01x	0.01x	0.01x	0.01x	0.00x	0.00x
Interest Coverage	216.41x	-	-	-	511.50x	-	-	-	-	-
FCF Conversion	1.19x	1.04x	1.36x	1.17x	1.96x	1.43x	2.19x	1.34x	-0.28x	-0.36x
Revenue Growth	20.86%	22.9%	14.51%	22.43%	11.73%	16.01%	10.52%	17.52%	13.09%	5.69%

SLP SEC Filings & Documents

Simulations Plus, Inc. (SLP) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

Material company update

Apr 9, 2026·SEC

Material company update

Feb 18, 2026·SEC

Material company update

Jan 8, 2026·SEC

10-K Annual Reports

FY 2025

Dec 1, 2025·SEC

FY 2024

Oct 30, 2024·SEC

FY 2023

Oct 27, 2023·SEC

10-Q Quarterly Reports

FY 2026

Apr 10, 2026·SEC

FY 2026

Jan 9, 2026·SEC

FY 2025

Jul 15, 2025·SEC

SLP Frequently Asked Questions

Simulations Plus, Inc. (SLP) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Simulations Plus, Inc. (SLP) reported $78.7M in revenue for fiscal year 2025. This represents a 2926% increase from $2.6M in 1996.

Simulations Plus, Inc. (SLP) grew revenue by 13.1% over the past year. This is steady growth.

Simulations Plus, Inc. (SLP) reported a net loss of $64.2M for fiscal year 2025.

Dividend & Returns

Simulations Plus, Inc. (SLP) has a return on equity (ROE) of -42.1%. Negative ROE indicates the company is unprofitable.

Simulations Plus, Inc. (SLP) generated $23.0M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

Explore More SLP

Simulations Plus, Inc. (SLP) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→

Simulations Plus, Inc.(SLP)Earnings, Financials & Key Ratios

SLP Key Insights

✓Strengths

✗Weaknesses

SLP Price & Volume

SLP Growth Metrics

Revenue CAGR

Profit CAGR

EPS CAGR

Return on Capital

SLP Recent Earnings

SLP Peer Comparison

Compare SLP vs Peers

vs VEEV

vs TMO

Compare Top 5

SLP Income Statement

SLP Balance Sheet

SLP Cash Flow Statement

SLP Key Ratios

SLP SEC Filings & Documents

8-K Announcements

10-K Annual Reports

10-Q Quarterly Reports

SLP Frequently Asked Questions

Explore More SLP

Total Return Calculator

DCA Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios

Valuation